Pharma Reviews: AstraZeneca, RSSDI ink pact for empowering 1 crore Indian Diabetic patients by 2023

Bangalore: AstraZeneca India (AstraZeneca Pharma India Limited), a science-led biopharmaceutical company, has recently signed a memorandum of ...
Read more: AstraZeneca, RSSDI ink pact for empowering 1 crore Indian Diabetic patients by 2023